Recombinant Human INSL4
Product Specifications
Product Name Alternative
Early Placenta Insulin-Like Peptide, EPIL, Insulin-Like Peptide 4, Placentin, INSL4
UniProt
Q14641
Expression Region
26-139
Host
Mammalian Cells
Tag
C-terminal His Tag
Applications
Western Blot, ELISA
Endotoxin
< 1 EU/µg as determined by LAL test.
Purity
Greater than 80% as determined by SDS-PAGE.
Form
Lyophilized powder
Reconstitution
Centrifuge the vial at 10000 rpm for 30 s before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/ml by gently pipetting 2-3 times, don't vortex.
Molecular Weight
9 kDa
Shipping Conditions
4°C with ice bag
Storage Conditions
The lyophilized protein is stable at -20 °C for up to 1 year. For extended storage, it is recommended to further dilute in working aliquots after reconstitution. The protein solution is stable at ≤ -20 °C for 3 months, or 2-7 days at 2-8 °C under sterile conditions.Avoid repeated freeze/thaw cycle.
Formulation
Lyophilized from a 0.2 μm filtered solution of 20 mM Tris, 150 mM NaCl, pH 8.0.
Organism Species
Human
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![5- (benzo[3,4-d]1,3-dioxolen-5-ylmethylene) -2-thioxo-1,3-thiazolidin-4-one](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
GHA76564 250 mg
5- (benzo[3,4-d]1,3-dioxolen-5-ylmethylene) -2-thioxo-1,3-thiazolidin-4-one
Sign In for Pricing
View Details 
